Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Company research history

Quest Diagnostics Incorporated Common Stock (DGX)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

8 disclosures

4 insiders

0 cluster signals

-0.7% avg. 30d outcome

Company facts

Ticker / ISIN: DGX / Not available
Exchange: Not available
Country: US
Sector: Not available

Related insiders

Carol Devine Miller

Representative, 3 disclosures

Earl Blumenauer

Representative, 1 disclosure

Julia Letlow

Representative, 2 disclosures

Kathy Manning

Representative, 2 disclosures

Disclosure history

Julia Letlow, Representative

buy disclosed on 13 Jan 2026 via House STOCK Act disclosures

View signal Open source

Transaction value: US$1,001
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Julia Letlow, Representative

sell disclosed on 13 Jan 2026 via House STOCK Act disclosures

View signal Open source

Transaction value: US$1,001
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Carol Devine Miller, Representative

sell disclosed on 11 Apr 2025 via House STOCK Act disclosures

View signal Open source

Transaction value: US$1,001
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Earl Blumenauer, Representative

sell disclosed on 4 May 2024 via House STOCK Act disclosures

View signal Open source

Transaction value: US$1,001
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: 0.0%

Carol Devine Miller, Representative

buy disclosed on 13 Dec 2022 via House STOCK Act disclosures

View signal Open source

Transaction value: US$1,001
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: -1.1%

Kathy Manning, Representative

sell disclosed on 14 Sept 2022 via House STOCK Act disclosures

View signal Open source

Transaction value: US$1,001
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: +2.3%

Carol Devine Miller, Representative

buy disclosed on 2 Sept 2022 via House STOCK Act disclosures

View signal Open source

Transaction value: US$15,001
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: +0.8%

Kathy Manning, Representative

buy disclosed on 10 Aug 2022 via House STOCK Act disclosures

View signal Open source

Transaction value: US$1,001
Copy Window: Probably too late
Data Confidence: 93%
Previous signal outcome: -7.8%